Home » Topics » Disease categories and therapies » Immune

Immune
RSS

AMD-3100 evaluated in healthy volunteers in combination with Neupogen

April 16, 2002

Product R to enter phase II as topical treatment for genital warts

April 16, 2002

HE-2200 for potentiating impaired immune systems

April 15, 2002

Oxxon Pharmaccines licenses MVA technology from Alpharma

April 12, 2002

Roche to codevelop ISAtx-247 with Isotechnika

April 11, 2002

Rhein Biotech licenses RC-529 for use in hepatitis B vaccines

April 11, 2002

Sankyo presents new immunosuppressants in recent patent

April 10, 2002

Berna Biotech and Iomai collaborate to develop transdermal patch vaccines

April 10, 2002

Phase I trial initiated for Cytovaxine in the prevention of P. aeruginosa infections

April 8, 2002

FluINsure influenza vaccine meets immune response endpoints in phase I trial

April 4, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...